Skip to main content
13/04/2007 - 09:18

pSivida sells AION Diagnostics for $3.6m

13/04/2007 - 09:18

Bookmark

Save articles for future reference.

Perth-headquartered bio-nanotech company pSivida Ltd has sold its subsidiary AION Diagnostics Inc to US-based private equity group GEM Global Yield Fund for around $3.6 million, following the company's float on the Frankfurt Stock Exchange.

X

To read our articles you will need to either login or subscribe.